Cardiovascular Renal Metabolic

Chim C Lang

Watch time: 3m 10s

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano , Aaron Wong, et al

ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s
ERA 25: eGFR Dips and Disease Severity on Empagliflozin

Watch time: 2m 52s
Real-World Data for CV and Renal Outcomes in DKD

David Wheeler

Watch time: 2m 39s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)

William Herrington

Watch time: 3m 10s (9 videos)
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s

David Wheeler, Carol Pollock,

Muthiah Vaduganathan

Sydney Tang , ,

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Andrew JS Coats, Stefan Anker

,

Watch time: 8m 53s (5 videos)

Neha Pagidipati, Linda Mellbin, , et al

Watch time: 2h (19 videos)

David K Ryan, Debasish Banerjee, Fadi Jouhra

Read time: 10m

Shelley Zieroth, ,

Watch time: 20m 16s (3 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Media

ERA 25: eGFR Dips and Disease Severity on Empagliflozin

Watch time: 2m 52s
ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano , Aaron Wong, et al

Chim C Lang

Watch time: 3m 10s
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera

Watch time: 8m 19s
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

William Herrington

Watch time: 3m 10s (9 videos)
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba

Watch time: 4m 19s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Articles

CVD in CKD Patients: Heart–Kidney Team-Based Approach

Gautam R Shroff

,

Michelle D Carlson

,

Roy O Mathew

,

Published:

07 December 2021

Citation:

European Cardiology Review 2021;16:e48.

DOI:

https://doi.org/10.15420/ecr.2021.30
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2091
  • Downloads: Downloads 103
  • Citations: 10

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies

Giuseppe Galati

,

Pierre Sabouret

,

Olga Germanova

,

Deepak L Bhatt

,

Published:

21 October 2021

Citation:

European Cardiology Review 2021;16:e40.

DOI:

https://doi.org/10.15420/ecr.2021.22
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2574
  • Downloads: Downloads 152
  • Citations: 12
  • Read time: 18m

APSC Consensus on Optimising CV Outcomes in T2D

Jack Wei Chieh Tan

,

David Sim

,

Junya Ako

,

Wael Almahmeed

,

Mark E Cooper

,

Jamshed Dalal

,

Chaicharn Deerochanawong

,

David Wei Chun Huang

,

Sofian Johar

,

Upendra Kaul

,

Sin Gon Kim

,

Natalie Koh

,

Alice Pik-Shan Kong

,

Rungroj Krittayaphong

,

Bernard Kwok

,

Bien J Matawaran

,

Quang Ngoc Nguyen

,

Loke Meng Ong

,

Jin Joo Park

,

Yongde Peng

,

David Quek

,

Ketut Suastika

,

Norlela Sukor

,

Boon Wee Teo

,

Chee Kiang Teoh

,

Jian Zhang

,

Eugenio B Reyes

,

Su Yen Goh

,

Published:

19 April 2021

Citation:

European Cardiology Review 2021;16:e14.

DOI:

https://doi.org/10.15420/ecr.2020.52
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2219
  • Downloads: Downloads 150
  • Citations: 5
  • Read time: 17m

Pharmacological Treatment of Type 2 Diabetes and CVD

Felipe Martínez

,

Published:

30 March 2021

Citation:

European Cardiology Review 2021;16:e12.

DOI:

https://doi.org/10.15420/ecr.2020.38
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1080
  • Downloads: Downloads 134